Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 175 participants.

Also called NCT05070494

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 175 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05070494
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Thailand (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05070494. Randomized; double masking; primary purpose treatment. Start 2021-03-01 (actual); primary completion 2022-04-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy of Different Doses of Influenza Vaccine in Chronic Hemodialysis Patients
Acronym
Enhance
Condition
ESRD
Condition
Influenza Vaccine
Condition
Seroprotection
Intervention (Biological)
Egg-derived standard dose trivalent influenza vaccine (surface antigen, inactivated)
Lead sponsor
Mahidol University (class: other)
Collaborator
Bhumirajanagarindra Kidney Institute, Thailand (class: other)
Collaborator
Ministry of Health, Thailand (class: other government)

Record details

Record id
cardio:ct-nct05070494
Content hash
9697065096fc469ca5fb9a2a93becde31daa1cd4cbab1332f30b8f9b90854151